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Abstract We first isolated and characterized genomic DNA
fragments that cover the 5P flanking sequences of COL4A3 and
COL4A4 encoding the human basement membrane K3(IV) and
K4(IV) collagen chains, respectively. Nucleotide sequence
analysis indicated that the two genes are arranged head-to-head.
To determine transcription start site for COL4A4 gene, we
performed RACE and RNase protection assays, indicating that
there are two alternative transcripts presumably derived from
two different promoters. Interestingly, one transcription start site
(from exon 1P) of COL4A4 is only 5 bp away from the reported
transcription start site of COL4A3, whereas the other transcript
(from exon 1) starts 373 nucleotides downstream from the first
one, generating the two kinds of transcripts that differ in the 5P
UTR regions. Expression of these two transcripts appears tissue-
specific ; exon 1 transcript was expressed predominantly in
epithelial cells, while exon 1P transcript showed rather ubiquitous
and low expression. The nucleotide sequence of the promoter
region is composed of dense CpG dinucleotides, GC boxes, CTC
boxes and a CCAAT box but no TATA box. These results
provide information to delineate the promoter activity for the
tissue-specific expression of the six type IV collagen genes and
basement membrane assembly in different tissues and organs.
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1. Introduction
The collagen superfamily now contains 19 molecules for-
mally de¢ned as collagens and at least 33 genetically di¡erent
collagen K chains [1]. The superfamily can be divided into
several classes on the bases of polymeric structural features,
expression manner, and gene structure: ¢brillar, FACIT,
basement membrane, short chain, multiplexins, and other col-
lagens [2]. One of them, basement membrane type IV colla-
gen, is composed of six genetically distinct K chains; K1(IV)
and K2(IV), the two major chains, and K3(IV), K4(IV),
K5(IV), and K6(IV), the four minor ones [3]. The six chains
di¡er with respect to their tissue distribution; i.e. K1/K2(IV)
are ubiquitous, whereas the other minor chains appear to have
a more restricted distribution [4]. The genes for the human
K1(IV) and K2(IV) chains, COL4A1 and COL4A2, are known
to reside closely together at locus q22 on chromosome 13 and
to form a transcription unit in which they are arranged head-
to-head and fused together by a common promoter region
[5,6]. A similar promoter arrangement for the genes of the
human K5(IV) and K6(IV) chains, COL4A5 and COL4A6, is
seen in region q22 of chromosome X; however, there are two
alternative promoters that drive the formation of two alter-
native transcripts from the COL4A6 gene [7]. This pair shares
some characteristic features in their 5P £anking region: the
lack of a TATA motif and the presence of CCAAT, GC
box and CTC box. In this report we describe the promoter
region of the human genes for K3(IV) and K4(IV), i.e.
COL4A3 and COL4A4, which are known to exist on chromo-
some 2 [8,9]. Nucleotide sequence analysis revealed the head-
to-head arrangement and the regulatory elements of the two
genes. Further, we demonstrate the presence of the two alter-
native transcripts for the COL4A4 gene, which were derived
from the presumptive alternative promoters.
2. Materials and methods
2.1. Cell culture
TCO-1 (thyroid carcinoma cell, [10]), MRC-9 (fetal lung ¢broblast),
TIG-1 (fetal lung ¢broblast, [11]), and IMR-90 (fetal lung ¢broblast)
cell lines were obtained through the Human Science Research Resour-
ces Bank (Osaka, Japan). Human retinal pigment epithelial cell (K-
1034) was described previously [12]. Cultured cells were grown in
75 cm2 plastic dishes in Dulbecco’s modi¢ed Eagle’s medium with
10% fetal bovine serum at 37‡C in 5% CO2 incubator.
2.2. cDNA cloning and screening of a genomic library
A Vgt11 cDNA library (Clontech, HL1123b) from human whole
kidney was screened by use of the previously described cDNA
(MS2) encoding the human K4(IV) chain as a probe [13]. Several
overlapping clones, shown in Fig. 1, were obtained and characterized
by nucleotide sequencing. The seven clones represented the entire
coding region of the human K4(IV) chain; and the amino-terminal
clone, MT107, contained a putative signal peptide and a part of the 5P
untranslated region. A total genomic library in EMBL3 (Clontech,
HL1006d) was screened, and the isolated clones were con¢rmed by
sequential Southern-blot analysis using a Sau96I fragment of MT107
(MT107Sau96I, Figs. 1 and 2) and an oligomer, A3L2, 5P-ATGG-
TGGGAGAGAGCTCAGA-3P, complementary to nucleotides 163^
144 of K3(IV) cDNA counting from the transcription start site [14],
on the assumption that the genes for K3(IV) and K4(IV) would be
closely together as observed for other K(IV) gene pairs [5^7]. DNA
labeling for probes and screening for clones were carried out by stand-
ard methods [15].
2.3. Nucleotide sequence analysis
Enzymatically fragmented phage clones were subcloned in double-
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stranded pBluescript II vectors and subjected to sequence analysis.
The £uorescence labeled dye-terminator method was used with an
Applied Biosystems model 373A automatic sequencer (Central Re-
search Laboratory, Okayama University Medical School). Sequence
was checked from both strands and was analyzed by the computer
program MacVector (Oxford Molecular Group PLC, UK).
2.4. Rapid ampli¢cation of cDNA 5P ends (RACE)
To determine the 5P end of the transcript and to see expression in
human tissues or cultured cells, we carried out 5P RACE [16]. Total
RNA was extracted from cultured retinal pigment epithelial (RPE)
cells by the guanidinium thiocyanate method [12], and 5 Wg of total
RNA was used as a template for synthesis of the ¢rst-strand cDNA.
We synthesized two primers, MT107R2: 5P-TTCTGCCAGT-
CTTCTCTTCC-3P (complementary to nucleotides 72^53 of exon 2
of COL4A4) and MT107R4: 5P-ACGTGAGGTTCTGTGTTCTG-3P
(complementary to nucleotides 35^16 of exon 2 of COL4A4). The
¢rst-strand cDNA was synthesized by Moloney murine leukemia virus
reverse transcriptase (United States Biochemical) from the MT107R2
primer and was tailed by a stretch of dA by terminal deoxytransferase
(GIBCO). Using a small aliquot of the reaction as a template we
performed PCR: 94‡C, 40 s; 58‡C, 1 min; 70‡C, 3 min for 40 cycles
for ampli¢cation, and 70‡C, 15 min for elongation. The products were
electrophoresed in 1.5% agarose gels, blotted onto Hybond-N
(Amersham) membranes, and hybridized with the two speci¢c probes:
RMg3-1PstI BamHI fragment (833 nt) for exon 1P (probe 1P, see Fig.
1) and RMg3-1BamHI XhoI fragment (603 nt) for exon 1 (probe 1).
Southern blotting was carried out by standard methods. Cloning of
the PCR products was performed by use of the TA cloning system
(Invitrogen).
2.5. RNase protection assay
Two primers (A3L5: 5P-CTCTCAGGCCACCGCGTCTC-3P (nt
560^579 in COL4A3, Fig. 3), RMgsp1: 5P-CGCGCCTCCCG-
CTTAATCTG-3P (nt 1023^1004, Fig. 3)) were designed for obtaining
the fragments encompassing each portion of the upstream exons of
both COL4A3 and COL4A4 genes by PCR. The generated fragments
were subcloned into pBluescript after some modi¢cations, thus ob-
taining the templates of cRNA probes (pBlBamL5). For K3 cRNA
probe production, pBlBamL5 was linearized with BamHI and tran-
scribed with T3 RNA polymerase. For K4 exon 1P cRNA probe, it
was linearized with EcoRI and transcribed with T3 RNA polymerase.
RMg3-1BamHIXhoI fragment was digested with NotI and was subcl-
oned into pCRII vector. This plasmid was linearized with BamHI and
transcribed with T7 RNA polymerase. These riboprobes were puri¢ed
with 7 M urea-5% polyacrylamide gel. Preparation of [K-32P]UTP
labeled cRNA probes and RNase mapping of the transcripts were
performed as described [15].
Ten micrograms of total RNAs were hybridized with each probe.
The procedure was followed by manufacturer’s manual (Amersham)
except that hybridization was performed at 45‡C. In each experiment,
10 Wg of yeast tRNAs were hybridized with each probe, as negative
controls. Samples were resolved in 7 M urea-5% polyacrylamide gels.
After electrophoresis the gels were dried and autoradiographed. All
experiments using radioisotope were done in Radioisotope Center,
Okayama University.
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Fig. 1. A: Schematic representation of the human K4(IV) chain and restriction enzyme map of the overlapping cDNA clones. Top: the relative
domain structure of the K4(IV) chain. The amino-terminal 7S domain, the central triple-helical domain, and the carboxyl non-collagenous do-
main are indicated by 7S, COL, and NC1, respectively. Bottom: restriction map with the consecutive cDNA sequence and corresponding
cDNA clones of MT107 (insert 0.5 kb in size), MT61 (0.8 kb), MT41 (0.6 kb), MT43 (1.7 kb), MT4 (1.8 kb), MT13 (2.2 kb), TM2 (1.9 kb),
MS2 (1.2 kb), and MS3 (2.5 kb). Restriction enzyme sites BamHI (B), EcoRI (E), and PstI (P) are shown. B: Schematic representation of
COL4A4 and COL4A3 on chromosome 2. Relative location of exon 1 for COL4A3, of exons 1 and 1P for COL4A4 in region 235 of chromo-
some 2 (top), and of the two isolated genomic clones, RMg2 and RMg3 (middle), is shown in a same scale. Exon-containing regions are mag-
ni¢ed in the two boxes to indicate how the two transcripts for COL4A4 are spliced. Restriction enzyme sites for BamHI and EcoRI are indi-
cated by B and E, respectively, below the two genomic clones. SalI sites (S) at both ends of the clones represent the cloning sites. Directions of
transcription are indicated by arrows. Note the two transcripts for COL4A4 starting from exons 1P and 1. Below the two boxes the MT107
cDNA is shown.
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2.6. Quantitative competitive PCR
To estimate promoter utilization rate of the two transcripts of
COL4A4, we performed quantitative competitive PCR analysis ac-
cording to the method by Fend et al. [17]. Two primer sets were
designed for speci¢c ampli¢cation of exon 1P and exon 1 containing
transcripts. The ¢rst set for exon 1P containing transcript was au2: 5P-
CCAACTTACCAGGCAGTGTC-3P (nt 751 to 770) and MT107R4
and the other set for exon 1 transcript was u2: 5P-GGGTG-
GCAAGGCGGCAGCT-3P (nt 1191 to 1209) and MT107R4. The
competitor for both exon 1P and exon 1 transcripts was generated
by PCR using au2u2: 5P-CCAACTTACCAGGCAGTGTCGG-
GTGGCAAGGCGGCAGCT-3P and glR4: 5P-AAGTGAGGTTCT-
GTGTTCTGACACAGCACCCAGTTAAAGC-3P (last half is com-
plementary to 1424^1405). This fragment was subcloned into plasmid,
cut out with appropriate restriction enzyme, puri¢ed with Prep-A-
gene (BIO-RAD). The concentration of competitor was determined
by spectrometry. One hundredth of reverse transcribed cDNA was
added into PCR reaction mixture with 10-fold serial dilutions of com-
petitor, 10 pmol of primers au2 or u2 and MT107R4 in 20 Wl of
reaction volume. The 30 cycles consisted of each reaction; 94‡C for
1 min, 62‡C for 1 min and 72‡C for 2 min. After ampli¢cation half of
reaction was resolved by 1.7% agarose gel containing 10 mg/ml EtBr.
This gel was photographed, scanned and analyzed using NIH image.
The logarithm of the ratio of transcripts to competitor was graphed
and used for estimation of the amount of transcripts.
3. Results and discussion
3.1. Isolation of genomic clones that contain the 5P upstream
region
We previously isolated and reported cDNAs encoding the
carboxyl part of the human K4(IV) chain [13]. Using one of
the cDNAs, MS2, as a probe, we started isolating overlapping
cDNAs covering the region further upstream. Seven consec-
utive overlapping clones, TM2, MT4, MT13, MT41, MT43,
MT61, and MT107 (Fig. 1A), were isolated and characterized
by nucleotide sequencing and Southern-blot analysis. We
identi¢ed that they encoded the human K4(IV) chain.
MT107 was found as the most upstream cDNA clone, encod-
ing a part of the 7S domain, a putative signal peptide and
some 5P untranslated region.
Isolation of genomic clones containing the 5P upstream re-
gion of COL4A4 was performed along with the cDNA clon-
ing. Two genomic clones of 20 kb in size, RMg2 and RMg3,
were isolated from a genomic library screened with the cDNA
probe MT107Sau96I (Sau96I-Sau96I fragment, 327 bp, Fig.
1B, bottom). Although both clones were isolated by use of the
MT107Sau96I probe, when a 3P fragment (HincII-EcoRI, 272
bp, Fig. 1B) of MT107 was used as the probe, RMg2 showed
hybridization; whereas RMg3 did not (data not shown). This
result indicated that RMg3 contained genomic DNA up-
stream from RMg2. The MT107Sau96I cDNA probe hybri-
dized to the RMg3 3 kb EcoRI-EcoRI fragment (Fig. 1B, left
box) of the genomic DNA. Further, in Southern-blot analysis
using the K3(IV) gene-speci¢c oligomer A3L2 (see Section 2)
as a probe, A3L2 showed hybridization to the whole RMg3
and to the EcoRI-EcoRI fragment of it as well. These results
suggested that the 3 kb EcoRI-EcoRI fragment contained the
upstream regions of both COL4A4 and COL4A3 genes.
To make sure that this clone was not an artifact, we di-
gested total human genomic DNA with EcoRI and hybridized
the digest with the RMg3PstIBamHI fragment (0.6 kb, Fig.
1B). This Southern-blot analysis (data not shown) resulted in
the detection of the 3 kb EcoRI fragment as expected and
con¢rmed the map shown in Fig. 1B. Nucleotide sequence
analysis revealed the presence of exon 1 and exon 2 of
COL4A4 in RMg3 and RMg2, respectively, and showed
that the ¢rst exons of both COL4A3 and COL4A4 were with-
in the 3 kb EcoRI-EcoRI fragment on opposite strands and
separated by 372 bp, indicating that the genes were tran-
scribed in opposite directions and shared the same promoter
region, as observed for other K(IV) genes [5^7].
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Fig. 2. A: Representation of the 5P RACE products and relative locations of probes. The ¢rst strand was synthesized from the R2 primer along
the RNA of RPE cells. 5P RACE was performed between hybrid primer and R4. The 5P RACE products thus synthesized were hybridized by
use of the two di¡erent probes. One group of the subclones that was hybridized with probe 1, the BamHI-XhoI fragment (603 bp) from
RMg3, contained exon 1 and a part of exon 2, which was the same as cDNA MT107. For the other group, the probe 1P, the PstI-BamHI frag-
ment (837 bp) of the RMg3, was used for subcloning. As expected the subclones contained the nucleotide sequence from exon 1P and the 5P
part of exon 2. The two di¡erent transcripts were thus recognized for the COL4A4 gene expression. B: Expression of the two transcripts.
RNAs from human lung (lane 1), kidney (lane 2), HeLa (human) cells (lane 3), retinal pigmented epithelial cells (4), thyroid carcinoma cells
(5), keratinocytes (6), arterial endothelial cells (7), di¡erent lines of fetal lung ¢broblasts (8^10), and adult skin ¢broblasts (11) were used as
templates for 5P RACE. The 5P RACE products were hybridized with the two di¡erent probes prepared from RMg3: probe 1 and probe 1P
(see panel A). Note the very low expression of exon 1-containing transcript in lung (lanes 8^10) and skin (lane 11) ¢broblasts.
R. Momota et al./FEBS Letters 424 (1998) 11^16 13
3.2. 5P RACE for K4(IV) cDNA
To identify the 5P termini of the K4(IV) transcripts, we
performed 5P RACE using RNAs from cultured human
RPE cells. The 5P RACE products hybridized with the
cDNA probe MT107Sau96I were sequenced. Three strongly
hybridized clones shared the nucleotide sequence with the
same 5P sequence in the non-translated region of MT107
cDNA, but their sequences were extended beyond the pre-
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vious report [18]. The longest was more extended with addi-
tional 74 nt, which was found in the genomic DNA sequence
of RMg3 that was described above. We designated this 5P
UTR with additional 74 nt as exon 1 (178 bp) for COL4A4.
There was a group of clones that hybridized weakly to the
cDNA MT107Sau96I. Nucleotide sequence analysis demon-
strated that the 3P 35 bp of the clones was the same as that
of an other group of clones found in exon 2 in the genomic
DNA sequence; however, the 5P side sequence of the clones
was di¡erent. The longest three clones contained 164 bp at the
5P side, which was located between the exon 1 for COL4A4
and the exon 1 for COL4A3 in the genomic DNA (Fig. 2A).
This indicates the presence of the alternative exon 1 for
COL4A4 and we designated this alternative 164 bp exon as
exon 1P. No clone had both exon 1P and exon 1 at the same
time, indicating that they were exclusively selected.
3.3. RNase protection assay
To con¢rm where the two transcripts start, we performed
RNase protection assay. As shown in Fig. 4, both probes were
protected at the predicted places: 720^730 for exon 1P, 1050^
1080 for exon 1. The assay also revealed the multiple pro-
tected bands for both transcripts. Multiple starting is a char-
acteristic feature of housekeeping genes that contain GC-rich
promoters with no TATA box. The transcription initiation
sites were thus determined for the two ¢rst exons in the 5P
RACE experiments. From comparison of the sequence be-
tween the genomic clone and the cDNA clones, we conclude
that there are two kinds of transcripts that di¡er in their 5P
end and are presumably driven from the two alternative pro-
moters.
3.4. Expression of the two transcripts of K4(IV) gene in
various human tissues and cultured cells
To examine the expression of the two transcripts of
COL4A4, we used Southern-blot analysis for 5P RACE prod-
ucts from RNAs of various human tissues and various kinds
of cultured cells. Genomic fragments of RMg3 were used as
probes for speci¢c detection of the two transcripts: probe 1
for transcripts starting from exon 1, and probe 1P for newly
found transcript starting from exon 1P (Fig. 2A). These two
probes determined the level of expression of the two alterna-
tive transcripts since they hybridized only with exon 1 or exon
1P. Interestingly, the newly found transcript was widely de-
tected by this method, whereas the level of transcript that
contained exon 1 was quite low in cultured ¢broblasts (Fig.
2B). When the sensitivity of this method is considered, cul-
tured ¢broblasts do not appear to represent major producing
cells of the transcript containing exon 1. Quantitative PCR
using the primer in exon 1 or exon 1P with reverse primer in
exon 2 (see Section 2 and Fig. 3) revealed that TCO-1 cells
preferentially utilized exon 1 promoter by 100-fold of exon 1P
promoter (data not shown).
3.5. COL4A3 and COL4A4 genes are transcribed to opposite
direction
As shown in Fig. 1, RMg3 contained a part of intron 1 and
exon 1 for COL4A3, the 5P termini of intergenic region for
both COL4A3 and COL4A4, exon 1P, exon 1 and a part of
intron 1 for COL4A4, and RMg2 contained exon 2 for
COL4A4 and introns. The nucleotide sequences of the pro-
moter region of the two genes and exon 2 for COL4A4 and
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Fig. 4. RNase protection assay was performed to determine the 5P
end structure of the two alternative transcripts, started from exon 1P
(panel A) and exon 1 (panel B). [K-32P]UTP labeled cRNA was syn-
thesized and hybridized to 10 Wg of total RNA derived from thyroid
carcinoma cell, TCO-1 (lane 2) and retinal pigment epithelial cell,
K1034 (lane 4). Yeast tRNA (10 Wg) was hybridized (lane 1) and
non-treated cRNA probe (lane 3) was included in each run to refer
the non-speci¢c signals. Protected bands, indicated by arrows, were
identi¢ed by comparison with exposed autoradiographs.
Fig. 3. Nucleotide sequence of the 1.4 kb PstI-XhoI fragment of RMg3 and exon 2 sequence of RMg2. A: A PstI-XhoI fragment of RMg3
(1.4 kb) that contains exon 1 for COL4A3 and exons 1 and 1P for COL4A4 was sequenced. Potential CCAAT box, GC boxes, CTC boxes and
19 nt tandem repeat are indicated in small shaded areas. Exons are indicated by boxed-in areas. The 5P ends of exon 1P and exon 1 of
COL4A4 are those of most extended clones. Transcription start sites estimated by RNase protection assay are indicated by vertical small ar-
rows. Transcriptional directions are indicated by arrows. Deduced amino acid residues for the COL4A4 translation product are shown below
the boxes in the one-letter code, whereas those for the COL4A3 product are shown above the boxes in inverted letters. Note that the transla-
tion starts within exon 1 for COL4A3, whereas both exons 1P and 1 for COL4A4 contain a 5P UTR sequence. Three bases at the nucleotides
531, 533, and 535 were reported as A but we con¢rmed as C from both strands. B: Nucleotide sequence containing exon 2 for COL4A4 was
determined from a RMg2 fragment. Exon 2 is indicated in a boxed-in area. Exon 2 contains the codon for the ¢rst methionine of the K4(IV)
chain.
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neighboring introns are shown in Fig. 3. Nucleotide sequence
comparison between the genomic DNA and cDNA for K4(IV)
and K3(IV) chains thus demonstrated that the two genes were
arranged head-to-head and transcribed in opposite directions.
A translation start codon was found in exon 2 of the COL4A4
gene, whereas it occurred in exon 1 for the COL4A3 gene.
Intriguingly, the COL4A4 gene generated two kinds of tran-
scripts that di¡ered in the 5P ends driven from the two pre-
sumptive alternative promoters, as mentioned above. An al-
ternative promoter is also found in the COL4A6 gene and
initiates transcription from di¡erent ¢rst exons, which results
in di¡erent signal peptides at the 5P termini [7]. As the two
transcripts of COL4A4 di¡ered only in the 5P untranslated
region, the deduced amino acid sequences in K4(IV) polypep-
tides would be the same.
Quite a few vertebrate genes have alternative promoters
[19]. The structures are di¡erent in each case and alternative
usage can in£uence gene expression in diverse ways. The level
of transcription initiation can vary between alternative pro-
moters which can have di¡erent tissue-speci¢city and respond
to extracellular signals. The shift in promoter usage sometimes
causes diseases [19]. Our data suggest that the transcripts con-
taining exon 1 show speci¢c expressions in some epithelial
cells, whereas those having exon 1P are ubiquitously expressed.
So similar utilization of K4(IV) promoters may be expected. It
is interesting to know whether the change in expression pat-
tern relates to abnormal conditions of basement membrane in
some diseases.
3.6. The 5P £anking region of COL4A3 and COL4A4
The 5P £anking region of both genes was composed of GC-
rich sequences with no canonical TATA box. The GC-rich
region spanned more than 1000 nucleotides with a GC con-
tent of 60^80% and contained many CpG dinucleotides, form-
ing a CpG island, in which the ¢rst exons of both genes were
embedded. The density of CpG dinucleotides was conspicu-
ously higher in exon 1 of COL4A3 and COL4A4 compared
with exon 1P of COL4A4. When compared with promoters of
other type IV collagen genes, high content of CpG dinucleo-
tides had been found in the COL4A1/A2 promoter as the
COL4A3/A4 promoter, while the COL4A5/A6 promoter con-
tained much less CpG dinucleotides (data not shown). Some
other consensus sequence motifs were found such as GC
boxes, consensus transcription factor Sp1 binding site, a
CCAAT box for COL4A3 and CTC boxes. Especially, the
most conspicuous one was a tandem repeat of 19 nt at
3120 to 381 of exon 1. Although how these elements regulate
the transcription of both COL4A3 and COL4A4 genes is yet
to be determined, they seem essential for appropriate tran-
scription, considering their roles in other collagen genes
[5,6,20^22]. It is true that the common promoter region of
the two genes is not su⁄cient for the proper expression of
both genes as COL4A1 and COL4A2 genes, since this region
alone is inactive [6,23]. Each gene contains an activator region
which activates the promoter either in the COL4A1 or the
COL4A2 direction [24,26]. There is a silencer element within
the third intron of COL4A2 which in£uences transcription in
both directions [25,26]. Although a head-to-head arrangement
may not be prerequisite for tight and synchronous regulation
of two genes, such an arrangement may be bene¢cial for many
functionally related genes.
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